Erste Group Downgrades AstraZeneca to Hold
Portfolio Pulse from Benzinga Newsdesk
Erste Group has downgraded AstraZeneca from Buy to Hold.
September 08, 2023 | 3:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AstraZeneca has been downgraded from Buy to Hold by Erste Group.
The downgrade from Buy to Hold by Erste Group indicates a less optimistic outlook for AstraZeneca's stock. This could potentially lead to a decrease in demand for the stock, and subsequently, a decrease in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100